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Summary: We report the evaluation of a new commercially available assay System for the determination of
serum pseudocholinesterase (EC 3.1.1.8) catalytic activity, and its application to a kinetic analyser.
The assay is based on the colorimetric method of Okabe et al. (Clin. Chim. Acta 80, 87—94 (1977)): choline,
liberated from benzoylcholine by pseudocholinesterase, is oxidized by choline-oxidase (EC 1.1.3.17) to be-
taine with the simultaneous production of hydrogen peroxide, which oxidatively couples with 4-aminoantipy-
rine and phenol in the presence of peroxidase to yield a coloured compound with maximal absorbance at
500 nm. The procedure not only has the advantage of being continuous, colorimetric and totally enzymatic
but also appears to be precise (between-day analysis gives coefficient of Variation between 3.5 and 5.6%) and
accurate; the results obtained from normal and pathological sera show excellent correlation with those ob-
tained by the alternative procedures employing propionylthiocholine, acetylthiocholine and butyrylthiocho-
line äs Substrates.
Bewertung einer neuen kontinuierlichen kolorimetrischen Methode zur Bestimmung der katalytischen Aktivität
von Pseudocholinesterase im Serum und ihre Anwendung an einem Zentrifugal-Analysengerät
Zusammenfassung: Wir berichten über die Bewertung eines neuen, kommerziell erhältlichen Bestimmungs-
verfahrens der katalytischen Aktivität von Pseudocholinesterase (EC 3.1.1.8) im Serum und ihre Anwendung
an einem Zentrifugal-Aiialyseilgerät. Die Bestimmung beruht auf der kolorimetrischen Methode von Okabe
et al. (Clin. Chim. Acta 80, 87—94 (1977)): Durch Pseudocholinesterase aus Benzoylcholin freigesetztes
Cholin wird durch Cholinoxidase (EC 1.1.3.17) zu Betain oxidiert; das dabei gebildete Wasserstoffperoxid
koppelt unter Einwirkung von Peroxidase 4-Aminoantipyrin und Phenol oxidativ zu einem Farbstoff mit
einem Absorptionsmaximüm bei 500 nm. Das Verfahren hat nicht nur den Vorteil einer kontinuierlichen,
kolorimetrischen vollenzymatischen Methode, sondern scheint auch genaue (VK von Tag zu Tag 3,5 bis
5,6%) und richtige Resultate zu ergeben. Die bei Untersuchung von Seren Gesunder und Kranker erhaltenen
Ergebnisse zeigen eine hervorragende Korrelation mit den Ergebnissen anderer Methoden, bei denen Ace-
tyl-, Propionyl·- und Bütyrylthiocholin als Substrat verwendet wird.
Introduction
The determination of serum pseudocholinesterase
(acylcholine acylhydrolase, EC 3.1.1.8) is commonly
requested äs a test of hepato^cellular function, to
monitor poisoning and excessive exposure to the an-
ticholinesterase organophosphorus insecticides and,
') Presented in part at the llth International Symposium on
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mainly, for the detection of patients with atypical
forms of the enzyme that could react abnormally
with succinylcholine (suxamethonium) employed äs
a muscle relaxant (l, 2). Indeed, failure of the atypi-
cal enzyme to hydrolyze succinylcholine may result
in prolonged apnoea in the patient during anaesthe-
sia. Finally, two recent reports (3,4) have suggested
that pseudocholinesterase catalytic activity may be
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important in the assessment of the risk for cardiovas-
cular disease.
Several mcthods have been developed for the deter-
mination of pseudocholinesterase. The numerous
colorimetric methods (5), using iodide salts of acetyl
(6-8), propionyl (9) and butyryleholine (8, 10, 11)
s Substrates, include the procedure of Ellman (6) in
which the Substrates behave similarly to choline es-
ters, and the thiocholine produced by enzymic hy-
drolysis can be measured by reaction with 5,5'-di-
thiobis(2-nitrobenzoic acid). In 1977, Okabe et al.
(12) described a new totally enzymatic approach to
determination of serum pseudocholinesterase cata-
lytic activity by estimating choline derived from ben-
zoylcholine using choline-oxidase and a coupled en-
zyme System. This paper reports the evaluation of a
new commercially available assay System, based on
this method, and its application to a kinetic analyser.
For reference, we chose the method of Dietz et al.
(9) adopted $$ a Selected Method by the American
Association for Clinical Chemistry, the method of
Garry & Routh (acetylthiocholine s Substrate) (7)
and the method of Das & Liddell (butyrylthiocholine
s Substrate) (10). There is no consensus among in-
vestigators s to the preferred assay temperature;
most determinations have been carried out at 25 °C
or 37 °C (13). The International Federation of Clini-
cal Chemistry has recommended that assay at 30 °C
should become the Standard procedure (14). It
therefore seems desirable not only to assess the com-
mercial kit at 30 °C but also to compare the results




Serum containing the homozygous "atypical" (E* E") enzyme
used for this study was obtained from hospital patients who expe-
rienced prolonged apnoea vvhen administred succinylcholine in
conjunction with surgery. "Heterozygous" (Ey E") and "usual"
(E" E") enzymes were obtained from members of families of those
individuals demonstrating the "atypical" enzyme and from pa-
tients in the Brescia area. Blood was taken from an antecubital
vein and allowed to clot; after centrifugation (1000g, 10 min), the
unhaemolysed serum was separated and stored at -20 °C until
required. Under such conditions of storage, cholinesterase cata-
lytic activity has been shown to be constant for several months
(13).
M e a s u r e m e n t of enzyme ca ta ly t i c ac t iv i ty
The pseudocholinesterase catalytic concentration was expressed
in terms of U/l serum (l Unit = l μπιοί of Substrate converted per
rminute) measured at 30 °C. All the enzymatic determinations
were carried out on Cobas Bio centrifugal analyser (F. Hoffmann
La R che and Co., Ltd., Basle, Switzerland). Analyses were per-
formed in triplicate and the mean value was calculated. For the
procedures involving the Ellman reaction (6), the enzymatic activ-
ity was calculated using 1360 m2 · mol'1 s the molar lineic absor-
bance value for 5-thio-2-nitrobenzoic acid, the product of the
reaction.
Propionylthiocholine s substraie
The Selected Method of Dien et al. (9) was used.
Butyrylthiocholine s Substrate
Pseudocholinesterase assay using butyrylthiocholine s Substrate
was performed according to the metho 'of Das & Liddell (W).
Acetylthiocholine s Substrate
The method of Garry & Routh (7) was used.
Dibucaine Inhibition
Dibucaine concentrations of 30 μηιοΐ/ΐ were used for the acetyl
and propionylthiocholine methods; to achieve a similar Inhibition
with butyrylthiocholine s the Substrate, a dibucaine concentra-
tion of 54 μηιοΐ/ΐ was needed (2). For the method under evalua-
tion, the Inhibition curve of pseudocholinesterase by dibucaine
was prepared with inhibitor concentrations varying from 30
μπιοΙ/1 to 5.0 irimol/l. The percentage Inhibition was calculated s
described previously (9).
Benzoylcholine s Substrate
The Enzyfast M A 701 Cholinesterase assay kit (product no.
7019) was a gift from Poli Industria Chimica, Milan, Italy. The
assay is based on the method of Okabe et al. (12): choline, which
is Hberated from benzoylcholine s Substrate by pseudocholineste-
rase, is oxidized by choline-oxidase (EC 1.1.3.17) to betaine with
the simultaneous production of hydrogeri peroxide, which oxida-
tively couples with 4-aminoantipyrine and phenol in the presence
of peroxidase (EC 1.11.1.7) to yield a coloured compound with
maximal absorbance at 500 nm. The molar lineic absorbance for
the dye formed under these conditions was 689m2 · mol"1.
The kit consists of separate reagents for enzymes and chrom gen,
buffer (tris(hydroxymethyl)aminomethane-hydrochloric acid, 0.2
mol/1, pH 7.5) and Substrate. To prepare the working solution, we
dissolved the Jyophilized enzymes and a tablet of Substrate in
20 ml of buffer; the final concentrations of the components in the
working solution were 1650 U/l choline-oxidase, 3 x 107 U/l per-
oxidase, 0.8 mmol/1 4-aminoantipyrine, 30 mmol/1 phenol and l
mmol/1 benzoylcholine Chloride.
Procedure
Cobas Bio was operated according to the usual protocol, the set-
tings being shown in table l, unless otherwise stated. Dibucaine
Inhibition studies were performed by the simple Substitution of
the reagent containing this material for the usual reagent.
Tab. l. Parameter listing for determination of pseudocholinester-
ase eatalytic activity on the Cobas Bio centrifugal an lys-
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Stutistical analysis
Calculations of means, Standard dcviations, cocfficients of Varia-
tion, correlation cocfficients and linear regression analysis were
carried out by Standard methods (15).
Results and Discussion
Determina t ion of pseudocholinesterase ca-
t a l y t i c adt iv i ty
A calibration curve relating serum volume to the hy-
drolysis of benzoylcholine was prepared, using se-
rum with catalytic concentration of 1978 U/I. The
hydrolysis of benzoylcholine was linearly related to
the volume of serum up to 3 μΐ (fig. 1). Investigation
of the effect of incubation time (lag time) on the lin-
earity of the enzymatic reaction showed that the best
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Fig. l. Effect of amount of serum used in the assay System on the
measured pseudocholinesterase catalytic activity.
Reagent s tabi l i ty
The wofking solution is stable for at least six days if
stored at 0-4 °C in a dark bottle.
L inea r i ty
Under the described assay conditions, the reaction is
linear up to 6500 U/l of serum pseudocholinesterase
(ΔA/min = 0.358); samples with values above this
were diluted appropiately in saline with no apparent
deleterious effects.
Precision
Precision studies using human sera with low, normal
and above-normal catalytic concentrations of pseu-
docholinesterase are shown in table2. The coeffi-
cient of Variation in serial analyses is between 2.9
and 4.6%; between-day analysis of 10 observations
for 4 different serum samples gives coefficients of
Variation between 3.5 and 5.6%.
Tab. 2. Precision of pseudocholinesterase determination by the
evaluated method.













































In te r fe rence s tudies
The addition of various kinds of anticoagulant, such
s ethylenediaminetetraacetic acid dipotassium sah,
sodium citrate, or lithium heparin had no effect on
the evaluated assay method. Sodium fluoride, how-
ever, is a known inhibitor of pseudocholinesterase
(16). Common serum components, i.e. triglycerides,
haemoglobin and bilirubin do not interfere up to
values of 22.5 mmol/1, 20 g/l and 340 μπιοΐ/ΐ, re-
spectively. Reducing substances, i.e. ascorbic acid,
glucose, creatiriine and uric acid do not interfere up
to values of 140 μπιοΐ/ΐ, 55 mmol/1, 4500 μιηοΐ/ΐ and
1800 μιηοΐ/ΐ, respectively.
Comparison wi th the reference m e t h o d s
As shown in figures 2, 3 and 4, correlation between
the values obtained with the evaluated method and
the reference methods was excellent, with correla-
tion coefficients between 0.973 and 0.984.
Reference i n t e r v a l
Since normal pseudocholinesterase values vary with
different Substrates used (13), we calculated the ref-
erence interval for the studied method with respect
to the reference methods, employing non-parametric
determination of percentiles (17) (tab. 3). Serum
pseudocholinesterase levels were determined in 700
healthy people with normal serum biochemical and
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Fig. 2. Correlation between total pseudocholinesterase catalytic
concentrations obtained with the evaluated procedure (x-
axis) and with the method of Dietz et al. (y-axis). Linear
regression analysis yields a regression equation of y =
2.41 χ + 79.45 (solid line) with a coefficient of correlation
of 0.980 and a Standard error of the estimate of 414.9.
Number of patients samples is 100.
Fig. 3. Cofrelation between total pseudocholinesterase catalytic
concentrations obtained with the evaluated procedure (x-
axis) and with the method of Das & Liddell (y-axis). Line-
ar regression analysis yields a regression equation of y =
2.58x + 77.12 (solid line) with a coefficient of correlation
of 0.984 and a Standard error of estimate of 398.8.
Number of patients samples is 100.
haematological tests and without clinical evidence of
liver diseaser (350 women and 350 men, whose ages
ranged from 10 to 65 years). The lower reference
limit for males is significantly higher than the value
for females (p < 0.001) (fig. 5); this sex difference
has been observed by other investigators (7, 8) and is
















Tab. 3. Reference interval for serum pseudocholinesterase cata-
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Fig. 4. Correlation between total pseudocholinesterase catalytic
concentrations obtained with the evaluated procedure (x-
axis) and with the method of Gany & Routh (y-^axis). Lin-
ear regression analysis yields a regression equation of y =
l.Olx + 100.50 (sol ' line) with a coefficient of correla^
tion of 0.973 and a Standard error of estimate of 203.7.
Number of patients samples is 100.
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Fig. 5. Histograms showing the frequency distribution of pseudo-
cholinesterase values of 350 healthy males (top) and 350
healthy females (bottom). The arrows point at the 0.025
and 0.975 fractiles (determined non-parametncally: 1850
and 3767 U/l for men, 1645 and 3756 U/l for women,













Dibucaine I n h i b i t i o n
Figure 6 shows the Inhibition curves of the three
pseudocholinesterase phenotype variants s a func-
tion of dibucaine concentration. From this figure one
can see that the maximum Inhibition differences
among the three phenotypes are approximately
—3.46 log molar dibucaine concentration, which cor-
responds to 350 μπκ>1/1 dibucaine concentration.
With this concentration, we reported a mean Inhibi-
tion of 78.5% (values ranged from 75 to 82%) for
70 subjects whose sera contained the "usual" en-
zyme, 68% Inhibition (values ranged from 45 to
72%) for 20 who had "heterozygous" enzyme and
27% (values ranged from 24 to 29%) for 10 who
had "atypical" sera. Regression equations from the
experimental data of the comparison of dibucaine
numbers, obtained with the enzymic and colorimet-
ric procedures, are presented in figures 7, 8 and 9; in
all instances, the enzymic method and colorimetric
methods appeared to agree. Therefore, with ben-
zoylcholine and dibucaine Inhibition, we could clear-
ly differentiate the genetic variants of pseudocholin-
esterase; besides, Kalow & Genest (19) first demon-
strated the ease with which the "usual" enzyme
could be distinguished from the "atypical" and "he-
terozygous" forms of the enzyme, using benzoylcho-
line s Substrate and dibucaine s differential inhibi-
tor.
Fig. 6. Curves of the Inhibition of "usual" and "atypical" forms
of serum pseudocholinesterase by dibucaine (30 μηηοΐ/ΐ to
5 mmol/1).
10 20 30 40 50 60 70
Inhibition by dibucaine (evaluated method) (%]
Fig, 7. Correlation diagram for dibucaine numbers (percentagc
of Inhibition) obtained with the evaluated method (x-axis)
vs those with the method of Dietz et al. (y-axis). The solid
line represents the regression equation, y = l. lOx + 4.48,
with a correlation coefficient of 0.950 and a Standard error
of the estimate of 4.93. Solid circie: "usuaf enzyme (40
samples); solid triangle: "heterozygous" enzyme (20 sam-
ples); solid square: "atypical11 enzyme (10 samples).
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Fig. 8. Correlati ri diagram for dibucaine numbers (percentage
of Inhibition) obtained with the evaluated method (x-axis)
vs those with the method of Das & Liddell (y-axis). The
solid line represents the regression equation, y = l .04x -
5.18, with a correlation coefficient of 0.972 and a Standard
error of estimate of 3.97. Solid circle: ^usual" enzyme (40
samples); solid triangle: "heterozygous" enzyme (20 sam-
ples); solid square: "atypical" enzyme (10 samples).
IQ 20 30 40 50 60 70 80
Inhibition by dibucaine (evaluated method) [%]
Fig. 9. Correlation diagram for dibucaine numbers (percentage
of Inhibition) obtained with the evaluated method (x-axis)
vs those with the method of Garry & Routh (y-axis). The
solid line represents the regression equation, y = 0.95χ +
7.39, with a correlation coefficient of 0.949 and a Standard
error of estimate of 5.04. Solid circle: "usual" enzyme (40
samples); solid triangle: "heterozygous" enzyme (20 sam-
ples); solid square: "atypical" enzyme (10 samples).
In conclusion, the evaluated procedure not only has
the advantage of being continuous, colorimetric and
totally enzymatic but also appears to be accurate,
precise and relatively simple to perform; its satisfac-
tory performance is indicated by the good agreement
between the results of the assay kit and the three
reference methods. Finally, this procedure appears
to be applicable to several different type of automat-
ic analysers.
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